Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-07-24

FDA Approved: SDAMLO — Original Application (Pangea Pharmaceuticals, LLC)

View source ↗

Summary

The FDA approved SDAMLO (amlodipine) under an Original Application (NDA 219531) by Pangea Pharmaceuticals, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SDAMLO (Amlodipine)

Snippet

ORIG AP for SDAMLO (AMLODIPINE)